Tag Archives: NurOwn®

BrainStorm Cell Therapeutics Inc, a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that it has successfully completed its first milestone in developing an innovative exosome-based platform-technology for the treatment severe COVID-19 infection. COVID-19 induced pneumonia ...

Read More »